Beright COVID-19/Influenza A+B/RSV Antigen Combo Lateral Flow Test
Detection of four respiratory viruses with one swab sample, eliminating the need for several tests. CTDA approved.
Prepare for winter season with the Beright SARS-CoV-2/Influenza A+B/RSV Antigen Combo Rapid Lateral Flow Test, a rapid chromatographic immunoassay for the qualitative detection of COVID-19, Influenza A, Influenza B and Respiratory Syncytial Virus (RSV). Save time and money with the detection of the four main respiratory viruses in a single test.
Prepare for the winter season with Beright COVID-19/Influenza A+B/RSV Antigen Combo Rapid Test.
The test is a rapid chromatographic immunoassay for the qualitative detection of COVID-19, Influenza A, Influenza B and Respiratory Syncytial Virus (RSV) antigens. Use with either nasopharyngeal or nasal swab specimens from individuals with suspected COVID-19/Influenza/RSV infection.
Results are provided in just 15 minutes, providing a cost effective way to test patients for multiple respiratory viruses at the point of care.
Accurate results with a single swab sample
For professional in vitro diagnostic use only
The test comprises of three lateral flow tests in a single cassette, for the detection of COVID-19, Influenza A+B and Respiratory Syncytial virus.
A nasopharyngeal or nasal swab is taken from the patient and placed in the provided extraction tube with extraction buffer. The sample tube is inverted and three drops are added to each of the three specimen wells. Results are read in 15 minutes.
During testing, the specimen migrates upward on the membrane by capillary action and reacts with the specific coated antibodies in test line region. If the specimen contains the target virus, a coloured line will appear in test line.
To serve as a procedural control, a coloured line will always appear in the control line region, indicating that the proper volume of specimen has been added and membrane wicking has occurred.